AETHLON MEDICAL, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
AETHLON MEDICAL, INC. (AEMD) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $783.87 thousand for the 12-month period ending 2017-03-31, per its 10-K filed 2018-06-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2018-06-08
- AETHLON MEDICAL, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2017 was $783.87K.
- AETHLON MEDICAL, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2015 was $527.78K.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|
| 2017-03-31 | $783.87K 10-K · filed 2018-06-08 |
| 2015-03-31 | $527.78K 10-K · filed 2016-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |